The -secretase complex represents an evolutionarily conserved family of transmembrane aspartyl proteases that cleave numerous type-I membrane proteins, including the -amyloid precursor protein (APP) and the receptor Notch. All known rare mutations in APP and the -secretase catalytic component, presenilin, which lead to increased amyloid -peptide production, are responsible for early-onset familial Alzheimer's disease. -amyloid protein precursor-like (APPL) is the Drosophila ortholog of human APP. Here, we created Notch-and APPL-based Drosophila reporter systems for in vivo monitoring of -secretase activity. Ectopic expression of the Notch-and APPL-based chimeric reporters in wings results in vein truncation phenotypes. Reporter-mediated vein truncation phenotypes are enhanced by the Notch gain-offunction allele and suppressed by RNAi-mediated knockdown of presenilin. Furthermore, we find that apoptosis partly contributes to the vein truncation phenotypes of the APPL-based reporter, but not to the vein truncation phenotypes of the Notch-based reporter. Taken together, these results suggest that both in vivo reporter systems provide a powerful genetic tool to identify genes that modulate -secretase activity and/or APPL metabolism.
INTRODUCTION
The -secretase complex, which consists of at least four proteins-Presenilin (PS), Nicastrin, Aph-1, and Pen-2, serves as a transmembrane aspartyl protease that plays a critical role in Alzheimer's disease (AD) and Notch signaling pathway (Bai et al., 2015; De Strooper, 2003; Fortini, 2009) . Amyloid -peptides (As), which are the main constituents of senile plaques present in the brain affected with AD, are generated by sequential cleavages of the -amyloid precursor protein (APP) by -secretase (BACE) and -secretase (Esler and Wolfe, 2001; Goedert, 2015) . Another well-known substrate for -secretase is Notch, whose signaling controls a large number of cell fate decisions during development (Fortini, 2009; Louvi and Artavanis-Tsakonas, 2006) . The cleavage of both APP and Notch within their single-pass transmembrane domains by -secretase releases cytosolic fragments and allows them to enter the nucleus, thereby regulating gene transcription (Brown et al., 2000; Cao and Südhof, 2001; Louvi and Artavanis-Tsakonas, 2006; Wang et al., 2014; Figs. 1A and 1B) . This -secretase-dependent regulated intramembrane proteolysis (RIP) is tightly controlled (Brown et al., 2000) , and thus alterations in the RIP of APP and Notch result in developmental defects and diseases (Esler and Wolfe, 2001; Louvi and Artavanis-Tsakonas, 2006 ).
Molecules and Cells
AD is the most common form of senile dementia characterized by the deposition of aggregation-prone As and neurofibrillary tangles in the brain (Selkoe, 1998) . Interestingly, early-onset familial Alzheimer's disease (EOAD) is caused by rare mutations in APP, PS1, and PS2 (Tanzi, 2012) . This is consistent with the fact that PS is the catalytic subunit of the -secretase complex whereas APP is a substrate for -secretase (De Strooper, 2003) . In addition, -secretase activity and A production were not detected in PS1/PS2 doubleknockout cells (Herreman et al., 2000; Zhang et al., 2000) . Therefore, -secretase serves as a therapeutic target to reduce A production and development of -secretase inhibitors can provide an effective therapy for AD. However, there is still one major concern that -secretase inhibitors might cause deleterious side effects because they also affect the RIP of numerous other substrates including Notch (Esler and Wolfe, 2001; McCarthy et al., 2009) . One possible approach to overcome this problem is to identify new therapeutic target genes that specifically affect the -secretase-dependent processing of APP rather than other substrates. To this end, we built a Drosophila reporter system for in vivo detection of -secretase activity by taking advantage of the Notch signaling pathway in the wing.
Canonical Notch signaling, which is highly conserved in the animal kingdom, is initiated by the binding of ligands including Delta, Serrate, and LAG-2 (Fortini, 2009; Louvi and Artavanis-Tsakonas, 2006) . Ligand binding induces sequential cleavages of the Notch receptor by ADAM family metalloproteases and -secretase, releasing the Notch intracellular domain (NICD) (Fortini, 2009; Louvi and Artavanis-Tsakonas, 2006) . NICD then enters the nucleus and forms an active transcriptional complex with the DNA-binding protein Suppressor of Hairless (Su(H)) and Mastermind (MAM), triggering expression of Notch target genes (Fortini, 2009; Louvi and Artavanis-Tsakonas, 2006; Fig. 1B) . In the absence of Notch signaling, Su(H) proteins associate with various corepressors to actively repress the transcription of Notch target genes (Fortini, 2009; Louvi and Artavanis-Tsakonas, 2006; Fig. 1B ). These findings demonstrate that Su(H) is the key effector of Notch signaling.
The Drosophila homolog of human APP is known as -amyloid protein precursor-like (APPL) (Martin-Morris and White, 1990) . Flies homozygous for Appl deletion allele showed a fast phototaxis defect that can be restored by human APP as well as fly APPL, revealing their functional conservation (Luo et al., 1992) . Furthermore, APPL is proteolytically cleaved by a BACE-like secretase (dBACE) and -secretase, producing a neurotoxic A-like fragment in Drosophila (Carmine-Simmen et al., 2009 ). However, dBACE does not appear to recognize and cleave human APP at the -secretase (BACE) cleavage site, suggesting the lack of a clear homolog of human BACE in Drosophila (CarmineSimmen et al., 2009; Greeve et al., 2004) . In contrast, each component and the activity of the -secretase complex appear to be evolutionarily conserved across invertebrates and vertebrates (De Strooper, 2003; Selkoe and Wolfe, 2007) . In support of this claim, Drosophila -secretase can cleave human APP and thus produce A peptides in combination with human BACE (Greeve et al., 2004) .
Here, we have created a Drosophila reporter system for in vivo monitoring of -secretase activity and it provides a genetic tool to discover novel genes that modulate -secretase-mediated RIP of Notch and APP-like (APPL), and APPL metabolism.
MATERIALS AND METHODS

Drosophila strains
The w 1118 Drosophila strain was used as a wild-type control.
The following flies were obtained from the Bloomington Stock
Center: UAS-psn RNAi (#27681), UAS-p35 (#5073), UAS-psn (#8310), e16E-GAL4 (#30557), and N Ax-E2 (#51660). The e16E-GAL4 enhancer trap line was shown to drive expression of a reporter gene in the striped pattern of engrailed during embryonic development (Weiss et al., 2001 ) and also in the posterior compartment of the wing imaginal disc during third instar larval stage (Johnson et al., 1995) .
Expression constructs
The UAS-N TM -SV and UAS-APPL-SV constructs were generated by PCR and/or restriction enzyme-based strategies and subcloned into the pUAST vector (Brand and Perrimon, 1993) . For the Litmus 28-Su(H)-VP16 (SV), a NcoI-PstI fragment from pGEX-Su(H) (Bailey and Posakony, 1995) , which contains the DNA-binding domain (amino acids 109-457; GenBank: AAF53434.1) of Su(H), and a PstI-XbaI fragment from pAct-GAL4-VP16 (Han and Manley, 1993) , which contains the transcriptional activation domain (amino acids 2-79; GenBank: AIZ65950.1) of VP16, were subcloned into the Litmus 28 vector (New England Biolabs, Inc.). For the Litmus 28-N TM -SV, a SalI-NcoI fragment from a Notch minigene clone (Wharton et al., 1985) , which contains the N TM (amino acids 1710-1891; GenBank: AAF45848.2), and a BglII-SalI fragment from Litmus 28-N ECN (Ju et al., 2000) , which contains the signal peptide region (amino acids 1-60) of Notch, were subcloned into the Litmus 28-SV. For the UAS-N TM -SV, a BglII-XbaI fragment from the Litmus 28-N TM -SV was subcloned into the pUAST vector. For the UAS-APPL-SV construct, a EcoRI-NcoI fragment from GH04413, which encodes the full-length APPL (amino acids 1-887; GenBank: AAF45520), and a NcoI-XbaI fragment from the Limus 28-SV, were subcloned into the pUAST vector. These construct sequences were confirmed by DNA sequencing. 
Immunohistochemistry
Expression patterns of transgenes were visualized using anti-VP16 monoclonal antibody (14-5, Santa Cruz Biotech.) and 3,3'-diaminobenzidine reaction, as described previously (Jeong et al., 2012; Kim et al., 1995 Fig. S1A ). The average percentages of L4 and L5 vein truncations were calculated by the following equations (see Supplementary Fig. S1B ): 
Statistical analysis
All quantitative data are presented as mean ± standard error of the mean (S.E.M.). Statistical significance was determined using unpaired t-test (*p < 0.05, **p < 0.01, and ***p < 0.001).
RESULTS
Generation of transgenic reporters for in vivo detection of the processing of Notch and APPL
We decided to take advantage of the Notch signaling pathway to generate transgenic reporters for in vivo detection of the activity of -secretase, which acts as a key player in Alzheimer's disease (AD) (Esler and Wolfe, 2001; Selkoe, 1998) . Notch is cleaved within its single-pass transmembrane domain by -secretase (Fortini, 2009; Louvi and ArtavanisTsakonas, 2006) . The cleavage of the Notch receptor releases its intracellular domain (NICD) and translocates it into the nucleus, thereby driving the expression of Notch target genes through the assembly of an active transcriptional complex with Su(H) and Mastermind (Fortini, 2009; Louvi and Artavanis-Tsakonas, 2006; Figs. 1A and 1B) . Vein pattern formation in the Drosophila wing is controlled by Notch signaling (de Cellis, 1998) . Reduction in Notch signaling activity leads to the formation of thicker veins, whereas increased Notch activity results in loss of veins (de Cellis and Garcia-Bellido, 1994a). These observations prompted us to examine whether Notch activity is correlated with vein phenotypes in a dose-dependent manner. Normal vein patterning was observed in wild-type females ( Fig. 2A (RNAi) technique. When the Drosophila presenilin (psn) gene was knocked down by overexpression of psn RNAi transgene using e16E-GAL4, which is expressed in the posterior compartment of the wing (Johnson et al., 1995) , wing patterns showed robust vein thickening but no vein truncation phenotypes (Figs. 2D and 2I ). This vein thickening phenotype, which is reminiscent of the phenotype found in type Psn (Fig. 2F) (Figs. 2G and 2H) . Taken together, these findings strongly suggest that -secretase activity contributes to vein pattern formation in the Drosophila wing through the Notch signaling pathway.
To monitor the proteolytic cleavage of Notch and APPL by -secretase within their transmembrane domains, we explored a sensitive reporter system, in which the chimeric transcriptional activator Su(H)-VP16 (SV) is fused to either a subfragment of Notch (N TM ) or full-length APPL (UAS-N TM -SV and UAS-APPL-SV in Fig. 1A ). The N TM subfragment possesses a transmembrane domain and the N-terminal region of NICD (Fig. 1A) . The SV was created by fusion of the DNAbinding domain of Su(H) transcription factor (Bailey and Posakony, 1995) and the transcriptional activation domain of the virus VP16 (Sadowski et al., 1988) (Fig. 1A) . Therefore, in case of nuclear translocation of the SV proteins, they are supposed to activate some of the Notch target genes, mimicking increased Notch pathway activity. Increased Notch activity in the wing can be visualized by the severity of the resulting vein phenotypes. Based on the fact that the N TM subfragment and APPL contain a -secretase-mediated cleavage site, we reasoned that the expression of both reporter transgenes under the control of e16E-GAL4 provides a sensitive assay for -secretase-dependent processing of Notch and APPL.
Expression of the notch-and APPL-based chimeric reporters in wings caused loss of wing veins To determine whether both the N TM -SV and APPL-SV chimeric reporter proteins transduce Notch signaling activity, we ectopically overexpressed these transgenes using e16E-GAL4 (Figs. 3E and 3H ). Ectopic expression of N TM -SV 61f in the posterior compartment of the wing resulted in moderate truncations of L4 and L5 veins in females (Fig. 3D) . These vein truncation phenotypes were not observed in wild-type, e16E-GAL4/ +, and N TM -SV 61f / + female wings (Figs. 3A-3C ). Interestingly, in females expressing APPL-SV 85m , we observed severe truncations of L4 and L5 veins (Fig. 3G) . However, vein pattern formation in females heterozygous for the APPL-SV 85m transgene was normal (Fig. 3F) . These findings might suggest that both the N TM -SV and APPL-SV reporter proteins were processed at least by -secretase, and they further demonstrate that the -secretase-cleaved C-terminal fragments of both reporters including the SV can transduce Notch activity in the wing. for L5 veins; Supplementary Fig. S3G ). In addition, we found that the APPL-SV 85m vein truncation phenotypes were robustly suppressed by RNAi-mediated knockdown of psn: from 84.8% to 51.2% for L4 vein truncations (p<0.001, ttest) and from 90.0% to 1.6% for L5 vein truncations (p < 0.001, t-test) (Figs. 5E-5G The role of apoptosis in reporter-induced wing vein truncations Since Notch plays a role in apoptosis during Drosophila visual system development (Bertet et al., 2014; Brachmann and Cagan, 2003) , we investigated whether Notch-mediated regulation of apoptosis is involved in patterning of the wing veins. Interestingly, females overexpressing the baculovirus pan-caspase inhibitor p35, which has been shown to prevent apoptotic death in Drosophila (Hay et al., 1994) (Supplementary Figs. S4B, S4E, and S4G) . Taken Supplementary Figs. S4C, S4F , and S4G).
Strong suppressive interactions between p35 and APPL-SV, especially in L4 veins suggest that overexpression of APPL-SV leads to cell death, and they further demonstrate that APPL-SV-induced cell death partly contributes to L4 vein truncation phenotypes. However, phenotypic enhancement observed in L5 veins, which is similar to that observed in females coexpressing p35 and N TM -SV (Fig. 6G) , suggests that apoptosis is not attributable to L5 vein truncation phenotypes of APPL-SV.
DISCUSSION
Drosophila melanogaster provides a powerful genetic tool to
analyze gene function associated with human diseases including Alzheimer's disease (AD) and evolutionarily conserved signaling pathways (Bier, 2005; Lu and Vogel, 2009) .
Indeed, many different Drosophila models of AD, which showed progressive degeneration through elevated production of amyloid -peptides (As), were developed (Fernandez-Funez et al., 2015) . Some of these AD models are based on overexpression of wild-type human APP, EOADassociated mutant APP, or a secreted form of human A42 peptide (Fernandez-Funez et al., 2015) . These findings demonstrate highly conserved mechanisms underlying A-mediated neurotoxicity and neurodegeneration between Drosophila and humans. This is further supported by the fact that the fly genome contains functional homologs for most of the EOAD-associated genes including APP, PS1, and PS2 (Martin-Morris and White, 1990; Stempfle et al., 2010) . In combination with human BACE, Drosophila -secretase is able to cleave human APP to generate Apeptides, indicating its conserved intramembrane proteolytic activity (Greeve et al., 2004) . Although the A sequence is not well conserved among APP homologs from different species, a growing body of evidence suggests that all APP homologs play an important and conserved role in neural development including neurite growth, axon guidance, and synaptogenesis (Nicolas and Hassan, 2014) . However, little is known about how -secretase-mediated proteolytic processing of APP is regulated at the molecular and genetic levels.
One of the hallmarks of AD is senile plaques largely consisting of As, which are produced by sequential cleavages of APP by -secretase (BACE) and -secretase (Esler and Wolfe, 2001; Goedert, 2015) . Given that all known mutations responsible for early-onset familial Alzheimer's disease (EOAD) are localized in APP, PS1, and PS2 (Tanzi, 2012) , -secretase represents a good therapeutic target for developing A-lowering drugs. Therefore, brain-penetrant inhibitors of -secretase are emerging as one of the most effective therapies for AD (De Strooper et al., 2010) . However, toxicity of -secretase inhibitors was found to be a major hurdle in preclinical studies since -secretase is also required for the RIP of numerous other substrates including Notch (De Strooper et al., 2010; Esler and Wolfe, 2001; McCarthy et al., 2009) . Here, as an alternative approach to overcome this targetbased toxicity, we report the development of a Drosophila reporter system for in vivo detection of -secretase activity. Based on several observations, we expect that this in vivo reporter system will provide a genetic tool to discover novel genes, which specifically modulate -secretase-mediated processing of Notch and APPL. First, overexpression of the N TM -SV reporter proteins in the wing induced vein truncation phenotypes that are totally dependent on -secretase activity. Second, not only -secretase activity, but also apoptosis contributes to the vein truncation phenotypes of the APPL-SV reporter transgene. This appears to be consistent with previous observations suggesting that human APP induces APP intracellular domain (AICD)-dependent cell death in Drosophila (Gunawardena and Goldstein, 2001; Wang et al., 2014) . Since the -secretase-cleaved C-terminal fragment of APPL-SV contains the APPL intracellular domain (dAICD) in addition to the SV, dAICD might be responsible for the contribution of apoptosis. Third, both N TM -SV and APPL-SV transduce Notch signaling activity in a dose-dependent manner. In support of this claim, reporter-induced vein phenotypes are enhanced by one copy of N , which is a Notch GOF allele. Fourth, APPL-SV-induced phenotype is almost 2-fold greater than the GOF phenotype of N TM -SV, probably due to differences in their RIP and the contribution of dAICD-dependent apoptosis.
Several -secretase associated proteins (GSAPs), in addition to the four main components of the -secretase complex, have been discovered (Chen et al., 2006; He et al., 2010; Teranishi et al., 2015; Wakabayashi et al., 2009; Zhou et al., 2005) . These GSAP proteins, including TMP21, pigeon homologue protein, and proton myo-inositol cotransporter, regulate substrate selectivity and A production. Therefore, these GSAPs can serve as therapeutic targets for the treatment of AD. These observations might indicate the existence of unknown GSAP proteins regulating A production without affecting proteolytic cleavage of other -secretase substrates including Notch. Future work using the in vivo reporter system developed in this study will determine whether known and additional unknown GSAP proteins are required for modulation of -secretase activity, and how substrate specificity of -secretase is regulated. Our current reporter system can also be applied to screening of chemical compound libraries.
Note: Supplementary information is available on the Molecules and Cells website (www.molcells.org).
